Skip to main content
Tracey McLaughlin, MD, Endocrinology, Stanford, CA, Stanford Health Care

TraceyMcLaughlinMDMS

Endocrinology Stanford, CA

Diabetes, Lipid Metabolism

Professor, Medicine - Endocrinology, Gerontology, & Metabolism, Stanford University Medical Center

Dr. McLaughlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McLaughlin's full profile

Already have an account?

Summary

  • I am a board certified endocrinologist with a sub-specialization in diabetes and metabolism. I see patients with type 1 and type 2 diabetes as well as hypoglycemia, polycystic ovary syndrome, and metabolic syndrome. I conduct clinical research on obesity, diabetes, and metabolism.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2000
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterResidency, Internal Medicine, 1994 - 1997
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1994
  • University of California, Berkeley
    University of California, BerkeleyMS, Public Health, 1991 - 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Metabolic Markers, Regional Adiposity, and Adipose Cell Size: Relationship to Insulin Resistance in African-American as Compared with Caucasian Women  
    Tracey McLaughlin, MD, Nature
  • Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies  
    Tracey McLaughlin, Adrian Vella, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

  • SARS-CoV-2 Can Infect Fat Cells, Promoting Infection & Inflammation
    SARS-CoV-2 Can Infect Fat Cells, Promoting Infection & InflammationOctober 13th, 2022
  • SARS-CoV-2 Infects Fat Tissue and Creates Inflammation
    SARS-CoV-2 Infects Fat Tissue and Creates InflammationSeptember 27th, 2022
  • The Coronavirus Infects Fat Cells, Study Shows
    The Coronavirus Infects Fat Cells, Study ShowsSeptember 23rd, 2022
  • Join now to see all

Hospital Affiliations